A method for diagnosing the risk of developing SOMATOALLERGICHESKIH reactions in the use of specialized infant foods (SPDP) WITH TEST SYSTEMS 'LAKTEST'

摘要

1.a test system u0434u043bu00a0 diagnosis risk u0440u0430u0437u0432u0438u0442u0438u00a0 u0441u043eu043cu0430u0442u043eu0430u043bu043bu0435u0440u0433u0438u0447u0435u0441u043au0438u0445 reactions in the application of specialized products, children's u043fu0438u0442u0430u043du0438u00a0 (u0441u043fu0434u043f) method u0438u043cu043cu0443u043du043eu0444u0435u0440u043c u0435u043du0442u043du043eu0433u043e analysis u043fu0440u0435u0434u0441u0442u0430u0432u043bu00a0u044eu0449u0430u00a0 three separate panels, u043au0430u0436u0434u0430u00a0 consists of two immunological and, u043fu0440u0435u0434u043du0430u0437u0430u043du0430u0447u0435u043du043du044bu0445 u0434u043bu00a0 u043eu043fu0440u0435u0434u0435u043bu0435u043du0438u00a0 end u043du0442u0440u0430u0446u0438u0438 class of immunoglobulins igg and ige.specific against food allergens, u0441u043eu0434u0435u0440u0436u0430u0449u0438u0445u0441u00a0 in u0441u043fu0434u043f, hole and the first panel u0441u0435u043du0441u0438u0431u0438u043bu0438u0437u0438u0440u043eu0432u0430u043du044b u0430u043du0442u0438u0433u0435u043du0430u043cu0438, u043fu0440u0435u0434u0441u0442u0430u0432u043bu00a0u044eu0449u0438u043cu0438 a summary beh u043bu043au043eu0432u043e - peptide fractions, the method of extraction from different medicinal mixtures, holes and the second panel u0441u0435u043du0441u0438u0431u0438u043bu0438u0437u0438u0440u043eu0432u0430u043du044b u0430u043du0442u0438u0433u0435u043du0430u043cu0438, u043fu0440u0435u0434u0441u0442u0430u0432u043bu00a0u044eu0449u0438u043c and the total protein and peptide fractions.the treatment and prevention of various mixtures, holes and third panels u0441u0435u043du0441u0438u0431u0438u043bu0438u0437u0438u0440u043eu0432u0430u043du044b u0430u043du0442u0438u0433u0435u043du0430u043cu0438, u043fu0440u0435u0434u0441u0442u0430u0432u043bu00a0u044eu0449u0438u043cu0438 protein - a summary peptide fraction isolated from different milk formulas on the basis of u043du0430u0442u0438u0432u043du044bu0445 proteins from breast milk, u0434u043bu00a0 u043au043eu043du0442u0440u043eu043bu00a0 background u043eu043au0440u0430u0448u0438u0432u0430u043du0438u00a0 use carbonate its buffer ph was 9 - 10.and u0434u043bu00a0 u043fu043eu0441u0442u0440u043eu0435u043du0438u00a0 calibration curve u0438u0441u043fu043eu043bu044cu0437u0443u044eu0442u0441u00a0 beta u043bu0430u043au0442u043eu0433u043bu043eu0431u0443u043bu0438u043d cow's milk.;2.method of diagnosing risk of u0440u0430u0437u0432u0438u0442u0438u00a0 u0441u043eu043cu0430u0442u043eu0430u043bu043bu0435u0440u0433u0438u0447u0435u0441u043au0438u0445 reactions using u0441u043fu0434u043f by u043fu0440u043eu0432u0435u0434u0435u043du0438u00a0 clinical and immunological response u0430u043du0442u0438u0433 u0438u0441u0441u043bu0435u0434u043eu0432u0430u043du0438u00a0 en antibody u0434u043bu00a0 u043eu043fu0440u0435u0434u0435u043bu0435u043du0438u00a0 concentrations of specific antibodies of class igg and / or ige immune enzyme analysis method, u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0, u043eu043fu0440u0435u0434u0435u043bu00a0u044eu0442 concentration yu igg and / or ige specific for allergens.u0441u043eu0434u0435u0440u0436u0430u0449u0438u0445u0441u00a0 in u0441u043fu0434u043f various types of test systems, as described in paragraph 1, and to increase the concentration of igg on more than 10 micrograms / ml and / or ige of more than 5 ng / ml dia u0433u043du043eu0441u0442u0438u0440u0443u044eu0442 risk u0440u0430u0437u0432u0438u0442u0438u00a0 u0441u043eu043cu0430u0442u043eu0430u043bu043bu0435u0440u0433u0438u0447u0435u0441u043au0438u0445 reactions against a specific type of u0441u043fu0434u043f.